Fingolimod

Sold as Tuvigin, Myelenea, Filengia, Glomatin, Modilex, Fingosol, Fingolimod alkem, Finkem, Domilo, Agilomid, Phinmo, Modlifin

C₁₉H₃₃NO₂307.50 g/mol

2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol

Drag to rotate. Structure from PubChem CID 107970.

Loading Wikipedia summary

Registration

Applicants: 10
Registrations: 12
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Novartis South Africa (Pty) Ltd	Tuvigin	0,5 mg	460023	S4	None
Forrester Pharma (Pty) Ltd	Myelenea	Not stated	500830	S4	None
Teva Pharmaceuticals (Pty) Ltd	Filengia	0,5 mg	520364	S4	PI PIL
Hetero Drugs South Africa (Pty) Ltd	Glomatin, Modilex	Not stated	520855, 520856.855	S4	None
Cipla Medpro (Pty) LtdCertificate held by Cipla medpro (pty)ltd	Fingosol	0,5 mg	530486	S4	PI PIL
Ascend Laboratories (Pty) Ltd	Fingolimod alkem, Finkem	Not stated	540338, 540339.338	S4	None
Adcock ingram limited	Domilo	0,5 mg	550548	S4	PI PIL
Austell Pharmaceuticals (Pty) Ltd	Agilomid	Not stated	550753	S4	None
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr Reddy’s Laboratories (Pty) Ltd	Phinmo	0,5 mg	550851	S4	PI PIL
Accord Healthcare (Pty) Ltd	Modlifin	0.5 mg	560213	S4	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Tuvigin 0,5 MG EACH CAPSULE CONTAINS FINGOLIMOD 0,5 mg	0,5 mg	46002346/34/0023	Registered	S4	None
Myelenea EACH CAPSULE CONTAINS FINGOLIMOD 0,5 mg	Not listed	50083050/34/0830	Registered	S4	None
Filengia	0,5 mgHard capsules.	52036452/34/0364Approved 2 June 2023	Registered	S4	PI PIL
Glomatin Each capsule contains FINGOLIMOD HYDROCHLORIDE EQUIVALENT TO FINGOLIMOD 0,5 mg	Not listed	52085552/34/0855	Registered	S4	None
Modilex Each capsule contains FINGOLIMOD HYDROCHLORIDE EQUIVALENT TO FINGOLIMOD 0,5 mg	Not listed	520856.85552/34/0856.855	Registered	S4	None
Fingosol 0,5 FINGOLIMOD HYDROCHLORIDE	0,5 mgCapsule	53048653/34/0486Approved 24 January 2023	Registered	S4	PI PIL
Fingolimod alkem EACH CAPSULE CONTAINS FINGOLIMOD 0,5 mg	Not listed	54033854/34/0338	Registered	S4	None
Finkem EACH CAPSULE CONTAINS FINGOLIMOD 0,5 mg	Not listed	540339.33854/34/0339.338	Registered	S4	None
Domilo EACH CAPSULE CONTAINS FINGOLIMOD 0,5 mg	0,5 mgCapsule	55054855/34/0548Approved 12 July 2022	Registered	S4	PI PIL
Agilomid EACH CAPSULE CONTAINS FINGOLIMOD HYDROCHLORIDE EQUIVALENT TO FINGOLIMOD 0,5 mg	Not listed	55075355/34/0753	Registered	S4	None
Phinmo 0,5 EACH CAPSULE CONTAINS FINGOLIMOD HYDROCHLORIDE 0,5 mg	0,5 mgCapsules	55085155/34/0851Approved 13 June 2023	Registered	S4	PI PIL
Modlifin 0,5 MG EACH CAPSULE CONTAINS FINGOLIMOD HYDROCHLORIDE EQUIVALENT TO FINGOLIMOD 0,5 mg	0.5 mgCapsule	56021356/34/0213Approved 18 April 2023	Registered	S4	PI PIL

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Fingolimod

S4: Fingolimod
Consolidated Schedules 06 July 2026, line 6341

Pharmacological class: Complementary Medicines: Health Supplements (class 34)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Filengia, Teva Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsFilengia, Teva Pharmaceuticals (Pty) Ltd Patient information leaflet (PIL)For patients and carersFilengia, Teva Pharmaceuticals (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background